# Recommendations for Reducing the Risk of Transfusion-Transmitted Hepatitis B Virus:  Guidance for Industry – FDA Guidance

Source: https://www.keypedia.com/guidances/guidance-document/recommendations-for-reducing-the-risk-of-transfusion-transmitted-hepatitis-b-virus-guidance-for-industry/4f8b1a40-446b-496a-884e-cb6031f8368b

> FDA guidance document: Recommendations for Reducing the Risk of Transfusion-Transmitted Hepatitis B Virus:  Guidance for Industry. Issue date: November 03, 2026. Get complete insights and analysis.

---

## Details

- Title: Recommendations for Reducing the Risk of Transfusion-Transmitted Hepatitis B Virus:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2026-11-03
- Last Changed: 2026-11-02
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2024-D-5942">FDA-2024-D-5942</a>

## Related Documents

- [Guidance for Industry: Potency Assurance for Cellular and Gene Therapy Products](https://www.keypedia.com/guidances/guidance-document/guidance-for-industry-potency-assurance-for-cellular-and-gene-therapy-products/b0c71ebb-a023-4038-8713-7a43757441d1)
- [Use of Serological Tests to Reduce the Risk of Transfusion-Transmitted Human T-Lymphotropic Virus Types I and II (HTLV-I/II):  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/use-of-serological-tests-to-reduce-the-risk-of-transfusion-transmitted-human-t-lymphotropic-virus-types-i-and-ii-htlv-iii-guidance-for-industry/e8ad35aa-47eb-47df-bcd6-5f95ecae4ee9)
- [Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis:  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/recommendations-for-reducing-the-risk-of-transfusion-transmitted-babesiosis-guidance-for-industry/027542ba-a0a9-4d9e-a1d0-46e29312bcf5)